http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd692f85100dd0b3ebf86859be730fc7
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Keegan |
| name | Patricia Keegan |
| given-name | Patricia |
| organization-name | Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA 1Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland. Authors' Affiliations: 1Office of Oncology Drug Products, Office of New Drugs; 2Office of Biostatistics; and 3Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 1Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. 1Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland Oncology Center for Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Center for Drug Evaluation and Research, US Food and Drug Administration, White Oak, Maryland 2U.S. Food and Drug Administration, Silver Spring, Maryland. Office of Hematology and Oncology Products, U.S. Food and Drug Administration, Silver Spring, Maryland, USA 1Office of Hematology and Oncology Products, FDA, Silver Spring, Maryland. U.S. Food and Drug Administration, Silver Spring, Maryland, USA Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Oncology Center of Excellence, Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, Maryland Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland (J.S., P.G.K., P.K.); Clinical Outcome Assessments Staff, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland (E.J.P.) Office of Oncologic Diseases, Silver Spring, Maryland, USA TopAlliance Biosciences, Rockville, Maryland U.S. Food and Drug Administration, Silver Spring, Maryland. Division of Biologic Oncology Products, Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Authors' Affiliation: Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland Structural Heart Program Emory University Atlanta Georgia Office of Hematology Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA 2Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Authors' Affiliations: 1Office of Hematology and Oncology Products, Office of New Drugs; 2Office of Biostatistics; 3Office of Clinical Pharmacology, and 4Office of New Drug Quality Assessment, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland Office of Hematology and Oncology Products and Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Office of Hematology and Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration 1Office of Hematology and Oncology Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Office of Oncology Drug Products, Office of New Drugs Food and Drug Administration Silver Spring, MD USA All authors: Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, White Oak, MD. Division of Cardiology, Emory Structural Heart and Valve Center Emory University Hospital Midtown Atlanta Georgia USA 1Office of Hematology and Oncology Products, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland. Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 1Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, FDA, Silver Spring, Maryland. Authors' Affiliations: 1Office of Hematology and Oncology Products, Office of New Drugs; 2Office of Biostatistics; 3Office of Clinical Pharmacology; and 4Office of New Drug Quality Assessment, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland Structural Heart and Valve Center Divisions of Cardiology, Emory University School of Medicine Atlanta Georgia Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, Maryland 1Oncology Drug Products, Offices of 2Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Structural Heart and Valve Center, Divisions of Cardiology Emory University Atlanta Georgia Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Division of Biological Oncology Products, Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA a Office of Oncology Drug Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA All authors: US Food and Drug Administration, Silver Spring, MD. Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland. Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. 1Office of Hematology and Oncology Products, U.S. Food and Drug Administration, Silver Spring, Maryland. |
Incoming Links
Total number of triples: 163.